Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: MiCrobiota-gut-brain Axis in Resistant Epilepsy [NA]

View source ↗

Summary

A clinical trial exploring the gut microbiota–brain axis in drug-resistant epilepsy is currently recruiting at Niguarda Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Niguarda Hospital | Conditions: Gut Microbiota, Epilepsy | NA | Status: RECRUITING